Michel Baudry

Neuraegis, Inc.

NIH Rank #45014
  • Early Career

NIH Funding · FY2024

Total Funding
$217.3K
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#45,014
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $217.3K across 2 grants · National rank #45014.

Top grants by award amount

Michel Baudry's NIH grant portfolio, ranked by award amount.

  • 5R41NS130825-02R41
    Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy
    $197.8K
    award amount
  • 3R41NS130825-02S1R41
    Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy
    $19.5K
    award amount

Affiliation

Institutions that have administered grants for Michel Baudry.

Affiliated with Neuraegis, Inc. (CA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Neuraegis, Inc.

Related investigators

Other NIH-funded PIs frequently associated with Michel Baudry.